ReWalk Now Lifeward: Medicare Milestone Achieved

Summary

• ReWalk Robotics has finally reached the goal of Medicare coverage for its personal exoskeleton medical device, and the Medicare claims are starting to get paid leading to drastic revenue expansion.
• ReWalk acquired another company in the rehab med-tech space, AlterG, broadening its product offering and expanding sales, but weakening its balance sheet and adding execution risk.
• Buying into ReWalk now is taking the position that the Medicare coverage and the AlterG acquisition will turbocharge growth from now to 2026 and beyond.

Unaihuiziphotography/iStock via Getty Images

Lifeward (NASDAQ:LFWD), formerly doing business as ReWalk Robotics Ltd., is a micro-cap medical device company that had its origins in creating a robot exoskeleton that assists people with spinal cord injuries to be able to walk. The

Analyst’s Disclosure:I/we have a beneficial long position in the shares of LFWD either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.